erythrosine has been researched along with Arrhythmias, Cardiac in 3 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postoperative treatment of ventricular arrhythmia with MSC is a promising procedure and merits further clinical and experimental investigation." | 1.26 | Antiarrhythmic effect of Mercurascan in patients after surgical treatment of ischaemic heart disease. ( Janota, M; Málek, P; Vrána, M; Vránová, Z, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vránová, Z | 1 |
| Janota, M | 1 |
| Málek, P | 2 |
| Vrána, M | 2 |
| Reidenberg, MM | 1 |
| Affrime, M | 1 |
| Kolc, J | 1 |
| Blazek, Z | 1 |
3 other studies available for erythrosine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Antiarrhythmic effect of Mercurascan in patients after surgical treatment of ischaemic heart disease.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; Drug Evaluat | 1976 |
Influence of disease on binding of drugs to plasma proteins.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Proteins; Blood Urea Nitrogen; Carbon Radioisotopes; C | 1973 |
Effect of mercury derivatives of fluorescein on the fibrillation threshold in experimental myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Fluoresceins; Mercury Isotopes; Myocardial In | 1971 |